Change of Director's Interest Notice (RP)
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
Imagion Biosystems Limited
ABN
42 616 305 027
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Robert Romeo Proulx
Date of last notice
23 August 2024
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
N/A
Date of change
13 December 2024
Note: Provide details of the circumstances giving rise to the relevant
interest.
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held prior to change
1. 154,082 Ordinary Shares
2. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2022, expiring 1 May 2026)
3. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2022, expiring 1 May 2027)
4. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2023, expiring 1 May 2028)
5. 2,000,000 Unlisted Performance Rights
(expiring 22 August 2028), comprising of:
(a) 600,000 Class A (Share price of
at least $0.10 over 20
consecutive trading days);
(b) 600,000 Class B (Market
capitalisation of at least $7.5
million over 20 consecutive
trading days);
(c) 800,000 Class C (Market
capitalisation of at least $12.5
million over 20 consecutive
trading days).
Class
Ordinary Shares
Unlisted Options
Number acquired
(a) 1,250,000 Ordinary Shares
(b) 625,000 Unlisted Options
Number disposed
N/A
Value/Consideration
(a) $25,000.00
(b) Nil
Note: If consideration is non-cash, provide details and estimated
valuation
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after change
1. 1,404,082 Ordinary Shares
2. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2022, expiring 1 May 2026)
3. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2022, expiring 1 May 2027)
4. 50,000 Unlisted Performance Options
(exercisable at $1.12, vesting on 1 May
2023, expiring 1 May 2028)
5. 2,000,000 Unlisted Performance Rights
(expiring 22 August 2028), comprising of:
(a) 600,000 Class A (Share price of
at least $0.10 over 20
consecutive trading days);
(b) 600,000 Class B (Market
capitalisation of at least $7.5
million over 20 consecutive
trading days);
(c) 800, 000 Class C (Market
capitalisation of at least $12.5
million over 20 consecutive
trading days).
6. 625,000 Options (exercisable at $0.04,
expiring 13 December 2027)
Nature of change
Issue of Placement Securities (Ordinary
Shares and Unlisted Options) which was
approved by Shareholders at the Company’s
General Meeting held on 9 December 2024.
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director’s Interest Notice
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed N/A
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was N/A
this provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011
Share your feedback
Discover